BREANN ESTES: Open Payments
NPI 1982244059 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 38 payments from 15 companies in 2025. Trend: 2023 $302 · 2024 $542 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $111 |
| Novo Nordisk Inc | 5 | $92 |
| Amgen Inc. | 4 | $61 |
| GlaxoSmithKline, LLC. | 4 | $61 |
| Verona Pharma, Inc. | 3 | $60 |
| Inspire Medical Systems, Inc. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| PFIZER INC. | 3 | $52 |
| Abbott Laboratories | 2 | $36 |
| ABBVIE INC. | 2 | $34 |
Products named: MOUNJARO, TRELEGY ELLIPTA, Ohtuvayre, JARDIANCE, INSPIRE, Ozempic, Wegovy, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
